Focus: Ferndale Pharma Group is a historic CDMO specializing in small-molecule contract manufacturing, headquartered in Michigan with operations since 1897. The company focuses on neurology, respiratory, and metabolic disease therapeutics.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Ferndale Pharma Group to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Company's sole revenue driver at pre-launch stage with minimal Part D spending, representing existential financial dependency.
Help build intelligence for Ferndale Pharma Group
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ferndale Pharma Group's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Branded prednisolone variant at pre-launch, duplicate asset with unclear differentiation or commercial pathway.
Third prednisolone formulation variant, further evidence of portfolio concentration on single API.
Post-LOE combination product with no measurable revenue contribution or growth prospects.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo